Our success as a boutique advisory firm can be attributed to a consistent focus on select life science industry segments where we have developed domain expertise and an understanding of the innovative and disruptive trends impacting the competitive landscape of our clients. Our deal making ethos is based on more than 25 years of experience structuring and negotiating complicated cross border transactions
The CATALYSIS team embodies an entrepreneurial culture that stems from first-hand experience. Whether as an investor, board member or management executive of a life science start-up, we know the unique challenges inherent in the healthcare development life cycle.
Many of our clients are referred to us by former clients or themselves are repeat clients. We are extremely proud of this and see this as a testament to our commitment as well as consistency and thoughtfulness of the counsel we provide.
CATALYSIS is owned entirely by its partners. This clearly differentiates us from many of our industry peers which are part of larger financial institutions. Our independence enables us to provide clients with unbiased, “non-agenda” driven advice, without conflicts of interest.